Disruption of Sp1 Expression in Schizophrenia
Author Information
Author(s): Ben-Shachar Dorit, Karry Rachel
Primary Institution: Rambam Medical Center, Technion Israel Institute of Technology, Haifa, Israel
Hypothesis
Is Sp1 expression abnormally regulated in schizophrenia, affecting mitochondrial complex I gene expression?
Conclusion
The study suggests that abnormal Sp1 expression may contribute to the complex genetic nature of schizophrenia.
Supporting Evidence
- Sp1 mRNA levels were significantly decreased in the prefrontal cortex and striatum of schizophrenia patients.
- Sp1 expression changes were correlated with the expression of mitochondrial complex I genes.
- Mithramycin treatment inhibited the expression of NDUFV1 and NDUFV2, indicating Sp1's regulatory role.
Takeaway
This study found that a protein called Sp1, which helps control other genes, is not working right in people with schizophrenia, which might explain some of their symptoms.
Methodology
The study analyzed mRNA levels of Sp1 and mitochondrial complex I subunits in postmortem brain tissues and lymphocytes from schizophrenia patients and controls.
Potential Biases
Potential bias due to the selection of postmortem samples and the influence of medication on gene expression.
Limitations
The study is limited by the small sample size and the potential effects of antipsychotic medications on gene expression.
Participant Demographics
Participants included 10 inpatients with schizophrenia and 10 age and sex-matched controls.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website